Ferreira Rui Seabra, Mantovani Cristina Kampus, Ferreira Ana Silvia Sartori Barraviera Seabra, Nascimento Laura de Oliveira, Ferrari Merari de Fátima Ramires, Kawano Daniel Fabio, Massirer Katlin Brauer, Anhê Gabriel Forato, Anholon Rosley, Caricati Celso Pereira, Ortega Luciane Meneguin, Guilbert Sarah, Lambe Teresa, Oliveira-Filho José Paes, Clemens Sue Ann Costa, Barraviera Benedito
Center for the Study of Venoms and Venomous Animals (CEVAP), São Paulo State University (UNESP), Botucatu, SP, Brazil.
Botucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.
J Venom Anim Toxins Incl Trop Dis. 2025 May 23;31:e20250005. doi: 10.1590/1678-9199-JVATITD-2025-0005. eCollection 2025.
In the biomedical field, translational science is the process of applying basic scientific knowledge to advance clinical research through the creation of new drugs, devices, medical procedures, preventive measures, and diagnostic kits. The Covid-19 pandemic exposed a shortage of professionals trained in translational research, essential for responding to global demands. To drive advancements, researchers must overcome the 'valley of death', a critical phase in clinical investigation. In response, CEVAP at São Paulo State University (UNESP), Botucatu, Brazil, has developed a strong 'knowledge industry' centered on Translational Science. As part of its research and innovation efforts, CEVAP has developed two biopharmaceuticals, the fibrin sealant and the apilic antivenom, which are currently in the final stage of development. In 2024, CEVAP began the first Brazilian Contract Development and Manufacturing Organization (CDMO) for developing and producing validated and qualified pilot-scale batches to generate clinical trial material.
The implementation of the optional undergraduate course in Translational Science marks a crucial step in strengthening the 'knowledge industry'. The program, developed in collaboration with São Paulo's three public universities (USP, UNESP, and UNICAMP), also involves an international partnership with the University of Oxford's Department of Pediatrics and the Oxford Research Group LATAM. The successful launch of this course underscores its importance in interdisciplinary education and institutional collaboration. By bridging gaps between research and application, the program equips professionals to meet the growing demand for expertise in translational science. Given the project's success, it will transition into a one-year 'Qualification in Translational Science', available to students enrolled in São Paulo state universities.
The preparation of these professionals will be strategic for transforming basic research into products for health, saving lives, and combating future pandemics that will emerge around the world.
在生物医学领域,转化科学是指通过研发新药、医疗器械、医疗程序、预防措施和诊断试剂盒,应用基础科学知识推动临床研究的过程。新冠疫情暴露出转化研究领域专业人才的短缺,而这些人才对于应对全球需求至关重要。为推动进展,研究人员必须跨越临床研究中的关键阶段“死亡谷”。作为回应,巴西圣保罗州立大学(UNESP)位于博图卡图的CEVAP建立了一个强大的以转化科学为核心的“知识产业”。作为其研究与创新工作的一部分,CEVAP已研发出两种生物制药产品,即纤维蛋白密封剂和阿皮利抗蛇毒血清,目前正处于研发的最后阶段。2024年,CEVAP成为巴西首个合同研发生产组织(CDMO),负责开发和生产经过验证且符合质量标准的中试规模批次产品,以生成临床试验材料。
开设转化科学本科选修课程是加强“知识产业”的关键一步。该课程由圣保罗的三所公立大学(USP、UNESP和UNICAMP)合作开发,还与牛津大学儿科学系及牛津研究小组拉丁美洲分部建立了国际合作关系。这门课程的成功推出凸显了其在跨学科教育和机构合作中的重要性。通过弥合研究与应用之间的差距,该课程使专业人员能够满足对转化科学专业知识日益增长的需求。鉴于该项目的成功,它将转变为面向圣保罗州立大学学生的为期一年的“转化科学资格课程”。
培养这些专业人员对于将基础研究转化为健康产品、拯救生命以及应对未来全球出现的大流行至关重要。